Article
BTBD9 is a novel component of IGF signaling and regulates manganese-induced dopaminergic…
medRxiv · 2021 · Chen, P.; Zheng, F.; Li, S.; Cheng, H.; Bornhorst, J.; Li, Y.; Yang, B.; Lee, K. H.; Ke, T.; Schwerdtle, T.; Yang, X.; Bowman, A. B.; Aschner, M.
Key facts
| Title | BTBD9 is a novel component of IGF signaling and regulates manganese-induced dopaminergic dysfunction |
|---|---|
| First author | Chen, P.; Zheng, F.; Li, S.; Cheng, H.; Bornhorst, J.; Li, Y.; Yang, B.; Lee, K. H.; Ke, T.; Schwerdtle, T.; Yang, X.; Bowman, A. B.; Aschner, M. |
| Journal | medRxiv |
| Published | Feb 22, 2021 |
| DOI | 10.1101/2021.02.18.431924 |
| Devices mentioned | K190495 |
| Product codes mentioned | DDG, NKB, MNH, MNI |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1